Artivion's Recent Announcements Regarding Investor Engagement
Artivion, Inc. (NYSE: AORT), a front-runner in cardiac and vascular surgical solutions, is thrilled to announce its participation in two investor conferences designed to enhance engagement with stakeholders and showcase the company's latest advancements in aortic disease treatment.
Participation at the Truist Securities MedTech Conference
Artivion's management team will take center stage at the Truist Securities MedTech Conference. This presentation is slated for Tuesday at the InterContinental Boston Hotel, marking a notable opportunity for the company to connect with investors. The presentation is anticipated to begin at 8:00 a.m. ET, contributing to valuable discussions around Artivion’s innovative product offerings.
Webcast Accessibility for Investors
For those unable to attend in person, a live webcast of the presentation will be available on Artivion's official website under the Investors section. After the event, an archived version of the webcast will remain accessible for 90 days, ensuring investors can catch up on key insights and developments presented.
Investor Meetings at the Citizens Medical Devices and Healthcare Services Forum
Following the MedTech Conference, Artivion also plans to engage in investor meetings at the Citizens Medical Devices and Healthcare Services Forum. This event is particularly important as it facilitates direct dialogue between the management and investors, though no webcast will be provided due to the event's format.
About Artivion
Artivion, Inc., headquartered in the Atlanta area, is committed to pioneering solutions that simplify complex challenges faced by cardiac and vascular surgeons treating aortic diseases. The company offers a diverse range of products, including aortic stent grafts, surgical sealants, On-X mechanical heart valves, and human tissues for implantable cardiac and vascular applications. Artivion proudly serves a global market, distributing its innovations in over 100 countries.
Inquiries and Contact Information
For any inquiries or more information regarding the upcoming conferences and Artivion’s offerings, interested parties can reach out directly to the company. Artivion's contact person is Lance A. Berry, the Executive Vice President and Chief Financial Officer, who brings extensive experience to the role.
For communications, please note the following contact methods:
- Phone: 332-895-3222
- For general inquiries, reach out at the provided phone number without disclosing personal email addresses.
Frequently Asked Questions
What is the focus of Artivion, Inc.?
Artivion focuses on developing medical devices that address critical challenges in cardiac and vascular surgeries, particularly related to aortic diseases.
When will Artivion present at the MedTech Conference?
The presentation at the Truist Securities MedTech Conference is scheduled for Tuesday at 8:00 a.m. ET.
How can investors access the webcast of the presentation?
Investors can access the live webcast through Artivion's official website in the Investors section, and it will be archived for 90 days afterward.
What types of products does Artivion offer?
Artivion provides a wide array of products including aortic stent grafts, surgical sealants, On-X mechanical heart valves, and human tissues for cardiac and vascular applications.
Who can be contacted for more information about Artivion?
Lance A. Berry, Executive Vice President and CFO, is the primary contact for additional inquiries related to Artivion and its events.
